Status:
UNKNOWN
Effectiveness of Compressive Bandage Use in Seroma Prevention
Lead Sponsor:
Instituto Nacional de Cancer, Brazil
Conditions:
Seroma
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
INTRODUCTION: Seroma is the most common complication after surgical treatment for breast cancer. It is the abnormal accumulation of serous fluid that develops under skin flaps and may be associated wi...
Detailed Description
This is a randomized clinical trial with women undergoing surgical treatment for breast cancer at Cancer Hospital III / INCA. All patients undergoing mastectomy will be evaluated for eligibility crite...
Eligibility Criteria
Inclusion
- Women aged 18 and over
- underwent mastectomy assurgical treatment for breast cancer.
Exclusion
- bilateral breast cancer;
- patient undergoing neoadjuvant radiotherapy;
- infection in the surgical wound or hematoma;
- autoimmune disease reporting (dermatomyositis, hidradenitis suppurativa, nephropathy, lupus erythematosus, morphea, psoriasis, pemphigus vulgaris, scleroderma);
- patients with difficulties in understanding.
Key Trial Info
Start Date :
November 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2023
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT04471142
Start Date
November 8 2021
End Date
March 30 2023
Last Update
September 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erica Alves Nogueira Fabro
Rio de Janeiro, Brazil, 20530-003